Waugh Jacob
Chief Scientific Officer at Revance Therapeutics, Inc.
- Sold, on record
- $2.6M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Sep 17, 2014
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Revance Therapeutics, Inc.Chief Scientific Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Revance Therapeutics, Inc.UnusualAug 18 2014
Sold 25,000 shares at $24.47 ($612k)
Waugh Jacob, Chief Scientific Officer
Sold 31.9% of holdings ($1.9M position)53,333 shares leftFirst sale on recordFiling
- 2 Form 4 sale Revance Therapeutics, Inc.UnusualSep 17 +30 days
Sold 97,713 shares at $20.73 ($2M)
Waugh Jacob, Chief Scientific Officer
Sold 79.6% of holdings ($2.5M position)25,000 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (2)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2014 | Revance Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 97,713 | $2M | 79.6% | Unusual | SEC |
| Aug 18, 2014 | Revance Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 25,000 | $612k | 31.9% | Unusual | SEC |